IL150034A0 - Oral mucosal dosage forms of apomorphine - Google Patents
Oral mucosal dosage forms of apomorphineInfo
- Publication number
- IL150034A0 IL150034A0 IL15003400A IL15003400A IL150034A0 IL 150034 A0 IL150034 A0 IL 150034A0 IL 15003400 A IL15003400 A IL 15003400A IL 15003400 A IL15003400 A IL 15003400A IL 150034 A0 IL150034 A0 IL 150034A0
- Authority
- IL
- Israel
- Prior art keywords
- apomorphine
- dosage forms
- oral mucosal
- mucosal dosage
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47584499A | 1999-12-30 | 1999-12-30 | |
PCT/US2000/034548 WO2001049292A1 (en) | 1999-12-30 | 2000-12-19 | Oral mucosal dosage forms of apomorphine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL150034A0 true IL150034A0 (en) | 2002-12-01 |
Family
ID=23889387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15003400A IL150034A0 (en) | 1999-12-30 | 2000-12-19 | Oral mucosal dosage forms of apomorphine |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1242088A1 (en) |
JP (1) | JP2004501065A (en) |
CN (1) | CN1414853A (en) |
AU (1) | AU2440901A (en) |
BR (1) | BR0012822A (en) |
CA (1) | CA2394297A1 (en) |
CZ (1) | CZ20022245A3 (en) |
HK (1) | HK1051315A1 (en) |
HU (1) | HUP0400495A3 (en) |
IL (1) | IL150034A0 (en) |
MX (1) | MXPA02006034A (en) |
NO (1) | NO20023190L (en) |
PL (1) | PL366204A1 (en) |
WO (1) | WO2001049292A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0202365D0 (en) | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
KR20050107401A (en) * | 2003-01-24 | 2005-11-11 | 마글레 홀딩 아베 | A composition material for transmucosal delivery |
SE0302947D0 (en) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
US8263121B2 (en) | 2004-04-14 | 2012-09-11 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical preparation |
GB0509317D0 (en) * | 2005-05-06 | 2005-06-15 | Clarke Anthony | Pharmaceutical formulation of apomorphine |
DK2952191T3 (en) * | 2009-06-12 | 2018-12-10 | Sunovion Pharmaceuticals Inc | Sublingual apomorphine |
CN114007617A (en) * | 2019-05-31 | 2022-02-01 | 葡瑞慕生物技术有限公司 | Unit dosage form for transmucosal administration of pharmaceutically active ingredients |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6428894A (en) * | 1993-03-26 | 1994-10-24 | Franciscus W.H.M. Merkus | Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
-
2000
- 2000-12-19 PL PL00366204A patent/PL366204A1/en not_active Application Discontinuation
- 2000-12-19 HU HU0400495A patent/HUP0400495A3/en unknown
- 2000-12-19 WO PCT/US2000/034548 patent/WO2001049292A1/en not_active Application Discontinuation
- 2000-12-19 IL IL15003400A patent/IL150034A0/en unknown
- 2000-12-19 CZ CZ20022245A patent/CZ20022245A3/en unknown
- 2000-12-19 AU AU24409/01A patent/AU2440901A/en not_active Abandoned
- 2000-12-19 BR BR0012822-8A patent/BR0012822A/en not_active IP Right Cessation
- 2000-12-19 JP JP2001549660A patent/JP2004501065A/en not_active Withdrawn
- 2000-12-19 EP EP00988174A patent/EP1242088A1/en not_active Withdrawn
- 2000-12-19 CN CN00818098A patent/CN1414853A/en active Pending
- 2000-12-19 CA CA002394297A patent/CA2394297A1/en not_active Abandoned
- 2000-12-19 MX MXPA02006034A patent/MXPA02006034A/en unknown
-
2002
- 2002-07-01 NO NO20023190A patent/NO20023190L/en not_active Application Discontinuation
-
2003
- 2003-03-14 HK HK03101912.0A patent/HK1051315A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CZ20022245A3 (en) | 2002-10-16 |
AU2440901A (en) | 2001-07-16 |
HUP0400495A2 (en) | 2004-06-28 |
PL366204A1 (en) | 2005-01-24 |
NO20023190D0 (en) | 2002-07-01 |
JP2004501065A (en) | 2004-01-15 |
MXPA02006034A (en) | 2004-08-23 |
CN1414853A (en) | 2003-04-30 |
CA2394297A1 (en) | 2001-07-12 |
HK1051315A1 (en) | 2003-08-01 |
NO20023190L (en) | 2002-08-29 |
WO2001049292A1 (en) | 2001-07-12 |
HUP0400495A3 (en) | 2007-05-02 |
BR0012822A (en) | 2004-03-09 |
EP1242088A1 (en) | 2002-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203204A3 (en) | Oral dosage forms | |
EG23943A (en) | Flash-melt oral dosage formulation | |
HK1090840A1 (en) | Extended release oral dosage composition | |
AU6089200A (en) | Rapid immediate release oral dosage form | |
EG23759A (en) | Stable extended release oral dosage composition | |
ZA200202480B (en) | Oral dosage forms. | |
PL364621A1 (en) | Nicotine-containing oral dosage form | |
AU2003238670A8 (en) | Fast disintegrating oral dosage forms | |
IL166337A0 (en) | Oral administration of calctionin | |
HUP0500638A3 (en) | Flashmelt oral dosage formulation | |
PL340456A1 (en) | Novel oral dosage form of carvedilol | |
IL150034A0 (en) | Oral mucosal dosage forms of apomorphine | |
HUP0201667A3 (en) | Oral form of administration | |
GB9923045D0 (en) | New oral formulations | |
PL352062A1 (en) | Oral solution of prucalopride | |
HUP0401599A3 (en) | Extended release oral dosage form | |
EP1210935A4 (en) | Medicinal compositions for oral use | |
HK1047232A1 (en) | Oral dosage forms | |
GB9925069D0 (en) | Oral dosage form | |
IL132006A0 (en) | Stable pharmaceuticl oral dosage forms | |
GB0014497D0 (en) | Oral dosage form | |
GB9911839D0 (en) | Invention related to oral hygiene | |
GB0030587D0 (en) | Oral administration of beneficial substances | |
PL341178A1 (en) | Oral pharmaceutical dosage forms | |
GB9930266D0 (en) | Oral administration of beneficial substances |